The MaxWell Collective

We are the MaxWell Collective, a science-driven, innovative medical technology company in development powered by a team of exceptional individuals. We're dedicated to advancing long-term, non-destructive solutions for patients with atrial fibrillation and HFpEF. Through cutting-edge research and relentless innovation, we’re pushing the boundaries of cardiac care to transform patient outcomes.

Randy Werneth
CEO, President

Meet our CEO and Chief Collective. With a track record of co-founding or founding several successful Medtech companies, this venture stands out as his most exciting and challenging yet. And that's exactly why he loves start-ups.


Timothy Corvi
Sr. VP, R&D

Meet Tim Corvi, our collective master maestro of product development. He channels his boundless passion into turning challenges into opportunities and driving our team to new heights. With over 20 years of designing breakthrough devices for interventional cardiology, cardiovascular surgery, drug infusion, and electrophysiology, his expertise is the heartbeat of our innovation.


Derrick Chou, PhD
VP, Science & Technology

Meet Derrick Chou, PhD, our collective spark and brainiac. A master of creative problem-solving, he focuses on finding and discovering what others have missed. His innovative spirit fuels our collective journey—making every breakthrough as fun as it is transformative.
Formerly CTO at Acutus Medical, he leverages a robust background in biomedical engineering and electrophysiology to fuel our collective drive for breakthrough cardiac innovations.


Ben Coppola, PhD
Director of SRT

Meet Benjamin Coppola, one of our collective sparks and brainiac. He masters the science of treating the root cause of AF without causing heart tissue damage, blending teamwork, strategic insight, and creative innovation to drive treatment success.


Walter Bomela, PhD
Dynamical Systems Scientist

Meet Walter Bomela, one of our collective chief brainiacs. With a blend of exceptional technical expertise and creative flair, he champions breakthrough cardiac solutions that keep every heartbeat in sync, embodying our team's spirit of innovation and collaboration.


J. Chris Flaherty
IP Strategist

Corey Werneth, Esq.
Finance & Legal

Meet J. Christopher Flaherty, one of our collective catalysts. With a talent for turning complex ideas into actionable patent strategies, he fuels our mission to protect the revolution happening in cardiac care, inspiring innovation and teamwork in every part of the Cardiac Collective.


Meet Corey Werneth, Esquire :-) one of our collective rule enforcers. Overseeing both our financial operations and legal affairs, he ensures every innovation investment is backed by smart strategy and rock-solid governance. With razor-sharp fiscal acumen and legal wizardry, Corey keeps our financial engine humming, fueling our journey toward breakthrough cardiac solutions.